30.11.2006

Canada: As of November 11, 2006, there have been 84 reports of adverse events occurring in Canadian patients using Tamiflu, including 10 which reported a fatal outcome. A causal relationship has not been confirmed in these cases. There have been seven Canadian reports of psychiatric adverse events, suspected by those reporting the events, due to Tamiflu, most involving elderly patients. There have been no Canadian reports of abnormal behaviour or deaths involving children.
FDA: "There have been postmarketing reports (mostly from Japan) of self-injury and delirium with the use of Tamiflu in patients with influenza. People with the flu, particularly children, may be at an increased risk of self-injury and confusion shortly after taking Tamiflu and should be closely monitored for signs of unusual behavior. A healthcare professional should be contacted immediately if the patient taking Tamiflu shows any signs of unusual behavior".
Japan: In February 2004, according to an online edition of Japan Times, a 17-year-old high school boy under treatment with Tamiflu died after he jumped in front of a truck.
A year later, a 14-year-old junior high student, also taking the drug for influenza, jumped to his death from the ninth floor of his condominium.
The newspaper also reported that Japan's Pharmaceutical and Medical Devices Agency -- the Japanese equivalent of the Food and Drug Administration -- has logged 64 cases of psychological disorders linked to Tamiflu.